Tumor cells evade immune destruction by activating immune checkpoint receptor proteins including cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein 1 (PD-1) found on T cells, and programmed death ligand 1 (PD-L1) found on tumor cells. Here, CTLA4 is linked to neoplasm.